{"id":1929,"date":"2026-08-20T15:00:00","date_gmt":"2026-08-20T15:00:00","guid":{"rendered":"https:\/\/lotilabs.com\/resources\/?p=1929"},"modified":"2026-09-01T16:09:24","modified_gmt":"2026-09-01T16:09:24","slug":"alpha-msh-%ce%b1-melanocyte-stimulating-hormone-melanocortin-signaling-anti-inflammatory-research-immunomodulation","status":"publish","type":"post","link":"https:\/\/lotilabs.com\/resources\/alpha-msh-%ce%b1-melanocyte-stimulating-hormone-melanocortin-signaling-anti-inflammatory-research-immunomodulation\/","title":{"rendered":"Alpha-MSH (\u03b1-Melanocyte-Stimulating Hormone): Melanocortin Signaling, Anti-Inflammatory Research &#038; Immunomodulation"},"content":{"rendered":"<div class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-light-blue ez-toc-container-direction\" id=\"ez-toc-container\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<p><span class=\"ez-toc-title-toggle\"><a aria-label=\"Toggle Table of Content\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" href=\"#\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg class=\"list-377408\" fill=\"none\" height=\"20px\" style=\"fill: #999;color:#999\" viewbox=\"0 0 24 24\" width=\"20px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg baseprofile=\"tiny\" class=\"arrow-unsorted-368013\" height=\"10px\" style=\"fill: #999;color:#999\" version=\"1.2\" viewbox=\"0 0 24 24\" width=\"10px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"><\/path><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav>\n<ul class=\"ez-toc-list ez-toc-list-level-1\">\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/lotilabs.com\/resources\/alpha-msh-%ce%b1-melanocyte-stimulating-hormone-melanocortin-signaling-anti-inflammatory-research-immunomodulation\/#Structural_Features_and_Stability\">Structural Features and Stability<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/lotilabs.com\/resources\/alpha-msh-%ce%b1-melanocyte-stimulating-hormone-melanocortin-signaling-anti-inflammatory-research-immunomodulation\/#Open_Research_Questions\">Open Research Questions<\/a><\/li>\n<\/ul>\n<\/nav>\n<\/div>\n<p>Alpha-melanocyte-stimulating hormone (\u03b1-MSH) is a 13-amino-acid peptide derived from the post-translational processing of proopiomelanocortin (POMC) in the anterior pituitary, hypothalamus, and various peripheral tissues. But that is barely the opening act.<\/p>\n<p>The melanocortin system comprises five receptor subtypes (MC1R through MC5R), and \u03b1-MSH activates most of them. <\/p>\n<p> Binding to MC1R on macrophages triggers a cAMP-dependent cascade that suppresses NF-\u03baB nuclear translocation. The effect is robust and reproducible across multiple cell lines and primary cultures.<\/p>\n<p>But MC1R is not alone. The effect was abolished in MC3R knockout animals, confirming receptor specificity.<\/p>\n<p>What distinguishes \u03b1-MSH from conventional immunosuppressants in preclinical research is selectivity. <\/p>\n<p> POMC neurons in the arcuate nucleus release \u03b1-MSH in response to leptin signaling, which then activates MC4R on second-order neurons in the paraventricular nucleus. <\/p>\n<p>This pathway\u2019s importance was demonstrated dramatically by genetic studies. MC4R knockout mice develop severe obesity. In humans, MC4R is the most commonly mutated gene in monogenic obesity \u2014 heterozygous loss-of-function mutations affect approximately 5-6% of individuals with severe early-onset obesity. <\/p>\n<p>Intriguingly, agouti-related peptide (AgRP) acts as an endogenous antagonist at MC4R, creating a push-pull system. The balance between \u03b1-MSH and AgRP at the MC4R determines the net orexigenic or anorexigenic signal. Researchers manipulating this balance in rodent models have achieved bidirectional control of feeding behavior with remarkable precision.<\/p>\n<p> Aqueous humor contains measurable concentrations of \u03b1-MSH, where it suppresses antigen-presenting cell activation and T-cell proliferation. <\/p>\n<p>This ocular research has broader implications. <\/p>\n<p>Melanocortin receptors are expressed in cardiac tissue and vascular endothelium. In isolated heart preparations and perfused vascular beds, \u03b1-MSH produces vasodilation through nitric oxide (NO)-dependent mechanisms. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Structural_Features_and_Stability\"><\/span><span class=\"ez-toc-section\" id=\"Structural_Features_and_Stability\"><\/span>Structural Features and Stability<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>\u03b1-MSH (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH\u2082) carries an N-terminal acetyl group and C-terminal amidation \u2014 modifications that enhance its resistance to aminopeptidase and carboxypeptidase degradation compared to unmodified POMC fragments. Even so, its plasma half-life is short, measured in minutes rather than hours.<\/p>\n<p>This instability drove the development of synthetic melanocortin analogs like NDP-\u03b1-MSH (Melanotan I), which substitutes norleucine for methionine at position 4 and D-phenylalanine for L-phenylalanine at position 7. These modifications dramatically extend half-life and increase receptor binding affinity, making NDP-\u03b1-MSH a valuable pharmacological tool for research \u2014 though it is a distinct compound from native \u03b1-MSH with different receptor selectivity profiles.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Open_Research_Questions\"><\/span><span class=\"ez-toc-section\" id=\"Open_Research_Questions\"><\/span>Open Research Questions<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Several frontiers remain. How does \u03b1-MSH signaling change across the lifespan? POMC neuron activity appears to decline with aging in rodent models, potentially contributing to age-related metabolic shifts. Does peripheral \u03b1-MSH production in keratinocytes, gut epithelium, and immune cells serve purely local (autocrine\/paracrine) functions, or does it contribute meaningfully to systemic melanocortin tone? Receptor subtype-selective analogs may hold the answer, but selectivity at the required level remains a design challenge in peptide chemistry.<\/p>\n<p><em>Disclaimer: This content is intended for research purposes only and is not meant to constitute medical advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Table of Contents Toggle Structural Features and Stability Open Research Questions Alpha-melanocyte-stimulating hormone (\u03b1-MSH) is a 13-amino-acid peptide derived from the post-translational processing of proopiomelanocortin (POMC) in the anterior pituitary, hypothalamus, and various peripheral tissues. But that is barely the opening act. The melanocortin system comprises five receptor subtypes (MC1R through MC5R), and \u03b1-MSH activates [&#8230;]\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1929","post","type-post","status-publish","format-standard","hentry","category-peptides"],"_links":{"self":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/comments?post=1929"}],"version-history":[{"count":0,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1929\/revisions"}],"wp:attachment":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media?parent=1929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/categories?post=1929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/tags?post=1929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}